Hikma Pharmaceuticals invests $1B to expand pharmaceutical manufacturing and R&D facilities in Ohio and New Jersey
Hikma Pharmaceuticals USA has announced plans to expand its pharmaceutical manufacturing and research and development capabilities in Columbus and Cleveland, Ohio, and Cherry Hill and Dayton, New Jersey. The company, which develops and manufactures a wide range of essential generic and injectable medicines, is investing $1 billion into the project and currently employs 2,300 people across its U.S. operations.
This expansion—part of the company’s long-term strategy to increase U.S.-based medicine production—will enhance capacity across four facilities. The upgrades will strengthen Hikma’s portfolio of more than 800 medicines and expand its ability to manufacture high volumes of injectable and oral solid products for American hospitals and healthcare providers.
What people are saying
In a recent quote, Dr. Hafrun Fridriksdottir, President, Hikma Rx, said, “We are proud to continue our ongoing investments in US manufacturing and R&D to better serve the needs of American patients. Hikma and our 2,300 dedicated US people are committed to supporting healthier communities nationwide by providing Americans with a steady and reliable supply of domestically produced quality medicines.”
Dr. Bill Larkins, President, Hikma Injectables, added, “Over the past 15 years Hikma has grown to become a top three US supplier of sterile injectable medicines with more than 180 injectable products in our portfolio and a growing pipeline. This new phase of US investment will enhance and expand our sterile injectables production capabilities and enable us to continue providing our broad portfolio of essential medicines to US patients.”
Manufacturers investing in Ohio
Mars invests $450M to open pet food manufacturing facility in Ohio
The new Royal Canin facility will produce enough dry pet food to feed 4 million cats and dogs annually.
United Alloy invests $48M to expand data center component manufacturing facility in Ohio
The expansion adds 350,000 square feet of space and will bring more than 400 total jobs to the Union area.
Amgen invests $900M to expand biologic medicines manufacturing facility in Ohio
This expansion brings Amgen’s total investment in Central Ohio to over $1.4 billion.
Investing in American manufacturing in 2025
This map shows where manufacturers are choosing to invest their resources, whether they are building new production facilities or expanding existing plants.